Article Details

Mersana Therapeutics Inc (MRSN) Given Average Rating of “Buy” by Analysts

Retrieved on: 2019-03-14 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Mersana Therapeutics Inc (MRSN) Given Average Rating of “Buy” by Analysts. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP purchased a new stake in Mersana Therapeutics in the 4th quarter worth about $277,000. Finally, Hikari Power Ltd ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo